IlluminaのSMA 200
IlluminaのSMA 200は何ですか。
Illumina, Inc.のSMA 200は$121 +2.63%です。
SMA 200の定義は何ですか。
SMA 200は、過去200日間の終値の非加重平均として計算された過去200日間の平均株価です。
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
LSEのセクタMiscellaneousにおけるSMA 200の企業と比べるIllumina
Illuminaは何をしますか。
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Illuminaと類似のsma 200
- Intercede plcのSMA 200はGBX121 +42.70%です。
- Jabil IncのSMA 200は$121 -16.90%です。
- Urban Logistics REIT plcのSMA 200はGBX121 -0.27%です。
- ArcBest CorpのSMA 200は$121 -22.49%です。
- CNOOCのSMA 200はCAD$121 -0.08%です。
- Trigyn TechnologiesのSMA 200は₨121 -4.46%です。
- IlluminaのSMA 200は$121 +2.63%です。
- Volkswagen AGのSMA 200は$121 -21.17%です。
- Datadog IncのSMA 200は$121 -10.67%です。
- Illumina IncのSMA 200は$121 +2.85%です。
- Keerthi IndustriesのSMA 200は₨121 -6.05%です。
- Trigyn TechnologiesのSMA 200は₨121 -4.67%です。
- PG&EのSMA 200は$121 -25.33%です。